GNH USA

Europe — EMA

Lenalidomide Teva

GNH USA supplies Lenalidomide Teva (Lenalidomide), an immunomodulatory drug for multiple myeloma and myelodysplastic syndromes. Request a quote for supply.

Lenalidomide

Request sourcing

1
Pack/s

What is Lenalidomide?

Lenalidomide, the active ingredient in Lenalidomide Teva, is an immunomodulatory drug (IMiD) presented as an oral tablet for oral use. It is indicated for the treatment of multiple myeloma and certain myelodysplastic syndromes in adult patients, and it follows EU‑mandated quality specifications.

GNH USA supplies Lenalidomide Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres and pharmacies worldwide, providing reliable sourcing for clinical and commercial programs. The company adheres to stringent Good Distribution Practice and offers temperature‑controlled logistics where required.

What is Lenalidomide used for?

Lenalidomide is used in hematologic malignancies and related bone‑marrow disorders, targeting abnormal plasma‑cell proliferation and dysplastic hematopoiesis. - Multiple myeloma: reduces disease progression and improves survival in eligible adult patients. - Myelodysplastic syndromes with del(5q): corrects cytopenias and decreases transfusion dependence. - Multiple myeloma maintenance: prolongs remission after autologous stem cell transplantation.

What are the side effects of Lenalidomide?

Lenalidomide may cause a range of adverse reactions, which are categorized by frequency and severity. Common Side Effects: - Fatigue - Neutropenia - Diarrhea Serious or Rare Side Effects: - Venous thromboembolism - Severe neutropenia leading to infection - Secondary primary malignancies

What precautions apply to Lenalidomide?

Before initiating therapy, clinicians should consider several safety measures. - Monitor blood counts: perform regular CBC to detect neutropenia or thrombocytopenia. - Assess thromboembolic risk: consider prophylactic anticoagulation in high‑risk patients. - Contraindicated in pregnancy: avoid use due to teratogenic potential. - Adjust dose in renal impairment: follow prescribing information for patients with reduced clearance. - Store at room temperature: keep in the original container, protect from moisture and light.

What does Lenalidomide interact with?

Lenalidomide can interact with other medicines, requiring careful management. Major Interactions (Avoid): - Strong CYP3A4 inhibitors: may increase lenalidomide exposure. - Live vaccines: risk of uncontrolled infection due to immunosuppression. - Anticoagulants: heightened risk of thromboembolic events. Moderate Interactions (Monitor Closely): - CYP3A4 inducers: may reduce efficacy. - Immunosuppressive agents: may augment hematologic toxicity. - NSAIDs: may increase risk of renal impairment.

Frequently asked questions

What is Lenalidomide Teva used for?+
Lenalidomide Teva is an oral immunomodulatory medication indicated for the treatment of adult patients with multiple myeloma and for certain myelodysplastic syndromes, particularly those with a del(5q) chromosomal abnormality. It helps control disease progression and can improve blood counts in these hematologic conditions.
How does lenalidomide work?+
Lenalidomide binds to cereblon, a component of the CRL4‑CRBN E3 ubiquitin ligase complex, altering the complex’s substrate specificity. This leads to degradation of transcription factors Ikaros and Aiolos, resulting in reduced cytokine production, inhibition of new blood‑vessel formation, and activation of immune cells that target malignant plasma cells.
What is the usual dose of Lenalidomide Teva?+
The prescribed dose of Lenalidomide Teva is determined by the treating physician based on the specific indication, patient’s renal function, prior therapies, and overall clinical status. Dosing regimens can vary, and the prescriber will tailor the schedule to achieve optimal therapeutic benefit while monitoring safety.
Is Lenalidomide safe in pregnancy or breastfeeding?+
Lenalidomide is classified as having unknown pregnancy category and is considered teratogenic. It should not be used during pregnancy, and effective contraception is required for both male and female patients of reproductive potential. Safety during breastfeeding has not been established, so breastfeeding is generally discouraged while on therapy.
How do I order Lenalidomide Teva from GNH USA?+
To request Lenalidomide Teva, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any temperature‑controlled logistics) and the necessary import documentation.
How does Lenalidomide compare with its main alternative drug?+
The primary alternative to lenalidomide in many hematologic settings is thalidomide. Compared with thalidomide, lenalidomide generally offers a more favorable safety profile, especially regarding peripheral neuropathy, and provides stronger anti‑angiogenic and immunomodulatory effects. Both drugs share a common mechanism through cereblon binding, but lenalidomide is often preferred for its potency and tolerability.
How should Lenalidomide Teva be stored and handled?+
Lenalidomide Teva tablets should be stored at room temperature, below 25 °C, in the original blister pack or container to protect them from moisture and light. Keep the product out of reach of children and avoid storing in humid environments such as bathrooms.
How is Lenalidomide Teva administered?+
Lenalidomide Teva is taken orally as a tablet. Patients should swallow the tablet whole with water, with or without food, as directed by their healthcare provider. The exact schedule (e.g., daily or on specific days of a cycle) is set by the prescriber based on the therapeutic indication.
What are the most serious risks associated with Lenalidomide Teva?+
The most serious risks include venous thromboembolism, severe neutropenia that can lead to life‑threatening infections, and the potential development of secondary primary malignancies. Patients should be monitored closely for signs of blood clots, infections, and any new cancer diagnoses throughout treatment.
Who should not use Lenalidomide Teva?+
Lenalidomide Teva should not be used by individuals who are pregnant, those who cannot use effective contraception, patients with known hypersensitivity to lenalidomide or its excipients, and patients with severe renal impairment unless dose adjustments are made. Clinicians must also evaluate contraindications related to concurrent therapies that pose high risk.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Lenalidomide
Route
Oral Use
Manufacturer
Teva B.V
Origin
EU

Related products

A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU